Investigational Site Number : 1240055

Hamilton, Ontario L8S 1G5

0 studies enrolling now · 1 studies all time

What they study most

Dermatitis Atopic

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis — Completed